The Sequence Code is the 5-step playbook Bryce built when standard treatment failed, and he took charge of his cancer. Cancer hides in your DNA—so he demanded genomic sequencing, unlocked the code, and pioneered a path that tripled his survival. It's the path the Motley Crew now hands to every patient who walks in scared—and walks out armed.
“You can do this, too.” — Bryce Olson
Five steps. You don’t have to start at one. Pick the door that matches where you are right now — you can always come back for the rest.
Cancer is a DNA disease. The same mutation that drives a lung tumor can drive a prostate or colon tumor — and the same drug can sometimes treat all three, though every cancer is its own puzzle. That's the whole idea behind personalized medicine: treat what's driving the cancer, not just where it showed up. But you only find the driver if someone looks. Push for comprehensive genomic profiling — it's increasingly standard, but it's not automatic. Learn the vocabulary first. Walk into the appointment armed.
Walk into your oncology appointment with the questions and the Battle Plan. Ask for comprehensive genomic profiling — most oncologists will be on board, and many will already have it in your plan. If it hasn't come up, ask. If you're dismissed, demand it. And before you go — check your coverage.
Your report comes back. It's confusing. Some mutations matter. They're driving the cancer and have drugs targeting them. Some don't. They're passengers along for the ride. Five questions cut through the noise.
Before you search for a trial, understand your standard of care. If you fit it, you have evidence on your side — that’s a strong position. Trials make sense when standard options are exhausted, insufficient, or unavailable for your markers. Start with your cancer care team first. Then use our suite of trial matching tools for molecular matching against your specific markers — EGFR, BRAF, KRAS, HER2, BRCA, PD-L1, MSI, TMB. Bryce enrolled in four trials at four cancer centers. One of them tripled his survival.
Cancer affects every area of your life: your family, your finances, your kids, your work, your body, your identity. The medical team treats your tumor. The Motley Crew points you to support for everything else.
advanced cancer patients never receive the molecular testing that could guide their treatment.
Sources: molecular testing rates — DaCosta Byfield et al., JAMA Network Open, 2025. New cases and deaths — American Cancer Society, Cancer Statistics 2026. Cancer types — National Cancer Institute.
Patients who unlocked their own code. Families who carry the story forward.
Would you or someone you know like to give a testimonial about the power of genomic sequencing and clinical trials? E-mail us at sequencemenow@gmail.com and we’ll send you simple guidelines, a release form — and a free Sequence Me Now tee shirt as an Encore Team welcome gift.
In the spring of 2014, Bryce collapsed mid-run. He was 44. The diagnosis was stage IV prostate cancer, already in his bones — and it came with a number: 21 months. He had a young daughter, a garage full of half-written songs, and no intention of letting that number be the end of the story.
An experienced volunteer crew — operators from NIKE, NVIDIA, Intel, and the Oregon & Montana healthcare systems, a nationwide nonprofit founder, and the daughter carrying his story forward — who all happened to be Bryce's people. They lead with the work. They carry his name.
Retired from NIKE after a 24-year career in Product Management and Merchandising, culminating in multiple VP roles. Active in Oregon Sports Angels and serves on multiple boards including Portland Tennis & Education.

At NVIDIA driving go-to-market strategy and ecosystem adoption for Arm-based CPU platforms. Previously 25 years at Intel across Product Management, Marketing, Sales, and Finance.

Multi-time CEO and CRO across SaaS and consumer brands — most recently founding sports coaching platform P3 and advising Revolin Sports on growth strategy. Co-founded Taylor's Gift Foundation, a nationwide nonprofit supporting organ and tissue donor families, after the loss of his daughter Taylor.

Breast cancer survivor diagnosed at 32. Founded Consano, a 501(c)(3) crowdfunding platform for medical research. Previously led patient advocacy for oncology start-up Manta Cares.

Retired from NIKE after a 34-year career culminating in Global VP roles across gender and sport. Now Principal at SVM Consulting, advising on brand, strategy, and product development.

23+ years as a Registered Nurse and public health professional. Montana native who understands rural communities' challenges in accessing advanced cancer treatment.

Bryce's daughter. Carrying his story to the next generation.

Devona is Bryce's beloved daughter, an inspiring 18-year-old and incoming freshman at Loyola Marymount University. After experiencing the profound loss of her father at the age of 15, she has transformed adversity into strength and purpose. During her high school years, Devona dedicated herself to the field of healthcare, volunteering in both hospital and memory care settings, and serving as an ambassador for SMN.
Bryce's faithful sidekick and the movement's four-legged mascot — keeping the Motley Crew grounded, loyal, and reminded why we show up.

Medical oncologist specializing in genitourinary malignancies and Associate Director for Clinical Trials at UCSD's Moores Cancer Center. Internationally recognized expert in advanced prostate cancer, precision medicine, and clinical trial design. Drove some of the field's most important biomarker-led trials.

Dr. McKay is a GU medical oncologist at UC San Diego. She and Bryce met in November 2017, three-and-a-half years into his diagnosis, when his cancer was progressing and he was pursuing personalized medicine — a non-standard approach for prostate cancer at the time. From their first visit, she met him where he was: reviewing imaging, genomic profiling, and trial options at every appointment, building a playbook that adapted as his disease changed. Together they used the treatments of tomorrow to extend his life today. Bryce exceeded his initial 21-month prognosis by fivefold.
Professor of Medicine and Deputy Division Head of Hematology and Medical Oncology in the Knight Cancer Institute at Oregon Health & Science University.
He has served as Senior Medical Advisor to the LIVESTRONG Foundation, Chief Medical Officer for Critical Mass: The Young Adult Cancer Alliance, the inaugural Chair of the AYA Committee for SWOG, on the expert advisory panel to the Children’s Oncology Group AYA Committee, a member of the CDC’s Federal Advisory Committee on Breast Cancer in Young Women, and on the Committee on Childhood Cancers and Disability for the National Academies of Sciences, Engineering, and Medicine.

Patient advocate, writer, and speaker focused on reengineering how cancer care is delivered. Former Harvard Business School research fellow. Hosts Reengineering Cancer Treatment, interviewing oncologists, researchers, and patients about systemic change. Deep operator's lens on what slows personalized medicine down.

Three commitments Bryce lived. Three commitments that shape every decision the Motley Crew makes.
Further the personalized medicine movement Bryce started by providing a hub of curated self-advocacy tools and resources — for patients, by patients.
Read The Mission →Bring personalized medicine to every patient — including in community hospitals & rural areas. Make cancer survivable.
Read The Vision →Four pillars Bryce lived: Education, Patient-Centricity, Innovation, Commitment. The E.P.I.C. foundation of our work.
Read The Values →My dad taught me that cancer doesn't get to write the last chapter. He wrote his — with music, with data, with every last wave. This movement is how he keeps writing.— Devona Olson · Bryce's Daughter
Newly diagnosed? Caregiver? Survivor? Donor? Whatever you are, there's a place in this. Bryce built it. You keep it going.
Sequence Me Now is a 501(c)(3) nonprofit. All contributions are tax-deductible to the extent allowed by law. EIN 93-4069873.